There is no need to panic as the Health Ministry has an adequate supply of flu vaccines in its healthcare facilities, says ...

Malaysia’s health ministry said there is no rising trend of influenza cases in Malaysia. Read more at straitstimes.com.

While demand for flu vaccines have spiked following news of the death of an international celebrity due to influenza ...

The latest health news covers topics such as the Trump administration's legal positions on transgender care, CDC research ...

Sanofi’s Q3 revenue grew by 12.3% to €13.438 billion, driven by products like Dupixent and influenza vaccines. Dupixent remains a top growth driver, with potential peak sales exceeding $20 ...

Learn more about whether Sanofi or Zoetis Inc. is a better investment based on AAII's A+ Investor grades, which compare both ...

“We’re all-in on the U.S.” As for Sanofi, the company commercializes a range of vaccines against influenza, polio, pertussis, Haemophilus influenzae type b-related illness, meningitis and ...

"In addition, Sanofi recently announced it received U.S. FDA Fast Track designation for two vaccine candidates combining our proven COVID-19 vaccine with its market-leading influenza vaccines. These ...

After two years characterized by layoffs, pipeline reorganizations, FDA delays and clinical holds, Novavax CEO John Jacobs ...

While the virus hasn’t made a sustained leap into humans, vaccines and treatments are being developed ahead of an outbreak.

The Sanofi Global Health Unit plays an important ... You don't have the same fee book effect that you have, for example, in influenza. I think that's an important differentiator to have in mind.

Early results from a trial testing a 2009 H1N1 influenza vaccine in children look promising, according to the trial sponsor, the National Institute of Allergy and Infectious Diseases (NIAID), part ...